Compare UNTY & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNTY | ABSI |
|---|---|---|
| Founded | 1991 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 523.6M | 577.4M |
| IPO Year | 1997 | 2021 |
| Metric | UNTY | ABSI |
|---|---|---|
| Price | $56.20 | $2.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $65.00 | $7.98 |
| AVG Volume (30 Days) | 48.8K | ★ 3.9M |
| Earning Date | 01-13-2026 | 03-17-2026 |
| Dividend Yield | ★ 1.07% | N/A |
| EPS Growth | ★ 39.66 | N/A |
| EPS | ★ 5.67 | N/A |
| Revenue | ★ $127,871,000.00 | $2,815,000.00 |
| Revenue This Year | $11.57 | $10.72 |
| Revenue Next Year | $8.52 | $313.07 |
| P/E Ratio | $9.90 | ★ N/A |
| Revenue Growth | ★ 23.99 | N/A |
| 52 Week Low | $36.65 | $2.01 |
| 52 Week High | $57.24 | $6.33 |
| Indicator | UNTY | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 64.36 | N/A |
| Support Level | $55.20 | N/A |
| Resistance Level | $57.00 | N/A |
| Average True Range (ATR) | 1.59 | 0.00 |
| MACD | 0.35 | 0.00 |
| Stochastic Oscillator | 97.54 | 0.00 |
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.